REG - Spire Healthcare Grp - Notice of AGM and Annual Financial Report

Spire HealthcareAnnouncement

Thu 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260409:nRSI8629Za&default-theme=true

RNS Number : 8629Z  Spire Healthcare Group PLC  09 April 2026

 

Spire Healthcare Group plc

 

2025 Annual Report and Notice of 2026 Annual General Meeting

 

9 April 2026

 

Spire Healthcare Group plc (LSE: SPI) ('Spire Healthcare', 'the Group' or 'the
Company'), a leading independent healthcare group in the UK, announced its
preliminary results for the year ended 31 December 2025 ('Preliminary
Announcement') on Thursday, 5 March 2026.

 

Further to the Preliminary Announcement, the Company confirms that its Annual
Report and Accounts for the year ended 31 December 2025 (the '2025 Annual
Report'), the Notice of 2026 Annual General Meeting and Form of Proxy have now
been published. Printed copies have been posted to shareholders who have
requested hard copies.

 

The following documents are now available on the Company's website and can be
accessed via investors.spirehealthcare.com
(https://investors.spirehealthcare.com/home/) :

 

-    2025 Annual Report
 

-    Notice of 2026 Annual General Meeting

 

In accordance with UK Listing Rule 6.4.1R, the Company will submit its 2025
Annual Report and other shareholder documents to the National Storage
Mechanism. These documents will be available for inspection shortly at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

In accordance with the Disclosure and Transparency Rules ('DTRs') the
regulated information required to be communicated under DTR 6.3.5R(1A) is
available in unedited full text within the 2025 Annual Report which will be
available both on the National Storage Mechanism and on the Company's website
at investors.spirehealthcare.com (https://investors.spirehealthcare.com/home/)
.

 

Arrangements for the Annual General Meeting

The Annual General Meeting of the Company will be held at 11.00am on Thursday,
14 May 2026 at 3 Dorset Rise, London EC4Y 8EN (the '2026 AGM').

 

The Company welcomes shareholders to attend the 2026 AGM in person, but they
are asked to monitor the Company's website should any changes in requirements
on attending the meeting be necessary.

 

The Board always welcomes questions from shareholders, and we request that
these are submitted by e-mail to companysecretary@spirehealthcare.com
(mailto:companysecretary@spirehealthcare.com) . A summary of questions and
responses will be put on the Company's website ahead of the meeting.

 

Details of the resolutions to be proposed at the 2026 AGM are set out in the
Notice of 2026 Annual General Meeting. The voting results of all resolutions
put before the 2026 AGM will be announced to the market following the meeting.

 

 

ENQUIRIES:

 

For further information please contact:

 

Spire Healthcare Group plc

Mantraraj Budhdev
                                                               0800
169 1777

Group General Counsel, Chief People Officer and
companysecretary@spirehealthcare.com
(mailto:companysecretary@spirehealthcare.com)

Company Secretary

 

Amie Gramlick
                            0800 169 1777

Director of Commercial Finance and Investor Relations
investors@spirehealthcare.com

 

About Spire Healthcare

Spire Healthcare (https://www.spirehealthcare.com/)  is a leading,
independent healthcare group in the United Kingdom, running 38 hospitals and
over 60 clinics across England, Wales and Scotland. Working in partnership
with over 8,800 experienced consultants, Spire Healthcare delivered tailored,
personalised care to over 1.36 million inpatients, outpatients and day case
patients, and workplace health clients, in 2025. It is the leading private
provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
 and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
 operations in the United Kingdom.

It operates a network of private GPs and provides workplace health
services to over 1,400 employers. It also delivers a range of private,
NHS and employer-funded mental health, musculoskeletal and dermatological
services, and is the largest independent provider of NHS talking therapies
in England.

Spire Healthcare's almost 100 well-located clinical sites deliver
award-winning care for self-pay patients, the NHS, employers and private
medical insurance ('PMI') providers. 98% of Spire Healthcare's inspected
locations are rated 'Good,' 'Outstanding', or the equivalent by health
inspectors in England, Wales and Scotland.

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAUKSARNNUSRAR



            Copyright 2019 Regulatory News Service, all rights reserved